GlaxoSmithKline Settles with Justice Department for $3 Billion
Steve Neavling ticklethewire.com Drugmaker GlaxoSmithKline will pay $3 billion and plead guilty to criminal and civil charges in connection with off-label marketing of several drugs under an agreement announced Monday by the Justice Department, according to the Philadelphia Inquirer. The London-based company is accused of illegally marketing prescriptions, including diabetes drug Avandia and the antidepressant…